Enlivex Therapeutics - 53 Year Dividend History | ENLV
Historical dividend payout and yield for Enlivex Therapeutics (ENLV) since 1971. The current TTM dividend payout for Enlivex Therapeutics (ENLV) as of November 20, 2024 is $0.00. The current dividend yield for Enlivex Therapeutics as of November 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.018B |
$0.000B |
|
Enlivex is a clinical stage immunotherapy company, developing an allogeneic drug pipeline for immune system rebalancing. Immune system rebalancing is critical for the treatment of life-threatening immune and inflammatory conditions which involve hyper-expression of cytokines (Cytokine Release Syndrome) and for which there are no approved treatments (unmet medical needs), as well as solid tumors immune-checkpoint rebalancing.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
